Health and Me on MSN7h
Why Do We Scratch An Itch When We Know It Hurts?
Scratching is something most of us do mindlessly. It doesn’t have to be a big deal, unless it is in hard to reach place. But ...
Medscape23h
Cutaneous Reactions to Transdermal Therapeutic Systems
In addition, 0.7% reported pruritus, and 0.5% reported an erythematous rash. [19] Several patients ... all of whom had negative reactions. [16] None of the reactions to buprenorphine TTSs have ...
Medindia19h
FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain
First Drug Approved in New Class of Non-Opioid Pain Medicines; Agency Continues to Take Steps to Support New Approaches for Pain Management Journavx is the first drug to be approved in this new class ...
FDA approves Vertex's first-in-class non-opioid analgesic for acute pain
Today, the U.S. Food and Drug Administration (FDA) gave its approval to Vertex Pharmaceuticals' (NASDAQ: NASDAQ:VRTX) ...
Axsome Therapeutics Hosts SYMBRAVO® FDA Approval Virtual Investor Event with Expert Thought Leader
Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, will ...